10-Q Filing

CARDINAL HEALTH INC CIK: 721371 Q2 2020

Filing Information

Form Type	10-Q
Accession Number	`0000721371-20-000023`
Period End Date	20191231
Filing Date	20200206
Fiscal Year	2020
Fiscal Period	Q2
XBRL Instance	a20q210q123119form10-q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 64 Income Statement 88 Cash Flow Statement 68 Stockholders Equity 56 Comprehensive Income 28

Balance Sheet 64 line items

Line Item	Tag	Value	Unit	Period
Preferred shares, authorized	`PreferredStockSharesAuthorized`	500,000.00	shares	Point-in-time
Preferred shares, authorized	`PreferredStockSharesAuthorized`	500,000.00	shares	Point-in-time
Preferred shares, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred shares, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Common shares, authorized	`CommonStockSharesAuthorized`	755.00M	shares	Point-in-time
Cash and equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.18B	USD	Point-in-time
Cash and equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.76B	USD	Point-in-time
Cash and equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.66B	USD	Point-in-time
Cash and equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.53B	USD	Point-in-time
Common shares, authorized	`CommonStockSharesAuthorized`	755.00M	shares	Point-in-time
Trade receivables, net	`ReceivablesNetCurrent`	$8.45B	USD	Point-in-time
Common shares, issued	`CommonStockSharesIssued`	327.00M	shares	Point-in-time
Trade receivables, net	`ReceivablesNetCurrent`	$8.28B	USD	Point-in-time
Common shares, issued	`CommonStockSharesIssued`	327.00M	shares	Point-in-time
Inventories, net	`InventoryNet`	$13.80B	USD	Point-in-time
Common shares in treasury	`TreasuryStockShares`	28.00M	shares	Point-in-time
Inventories, net	`InventoryNet`	$12.82B	USD	Point-in-time
Common shares in treasury	`TreasuryStockShares`	35.00M	shares	Point-in-time
Prepaid expenses and other	`OtherAssetsCurrent`	$2.00B	USD	Point-in-time
Prepaid expenses and other	`OtherAssetsCurrent`	$1.95B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$25.74B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$25.75B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$2.36B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$2.30B	USD	Point-in-time
Goodwill and other intangibles, net	`IntangibleAssetsNetIncludingGoodwill`	$11.52B	USD	Point-in-time
Goodwill and other intangibles, net	`IntangibleAssetsNetIncludingGoodwill`	$11.81B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.48B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.05B	USD	Point-in-time
Total assets	`Assets`	$41.04B	USD	Point-in-time
Total assets	`Assets`	$40.96B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$21.54B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$21.46B	USD	Point-in-time
Current portion of long-term obligations and other short-term borrowings	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$1.19B	USD	Point-in-time
Current portion of long-term obligations and other short-term borrowings	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$452.00M	USD	Point-in-time
Other accrued liabilities	`OtherAccruedLiabilitiesCurrent`	$2.12B	USD	Point-in-time
Other accrued liabilities	`OtherAccruedLiabilitiesCurrent`	$2.24B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$24.89B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$24.11B	USD	Point-in-time
Long-term obligations, less current portion	`LongTermDebtAndCapitalLeaseObligations`	$7.58B	USD	Point-in-time
Long-term obligations, less current portion	`LongTermDebtAndCapitalLeaseObligations`	$6.74B	USD	Point-in-time
Deferred income taxes and other liabilities	`DeferredTaxAndOtherLiabilitiesNoncurrent`	$8.41B	USD	Point-in-time
Deferred income taxes and other liabilities	`DeferredTaxAndOtherLiabilitiesNoncurrent`	$2.94B	USD	Point-in-time
Authorized500 thousand shares, Issuednone	`PreferredStockValue`	-	USD	Point-in-time
Authorized500 thousand shares, Issuednone	`PreferredStockValue`	-	USD	Point-in-time
Authorized755 million shares, Issued327 million shares at December 31, 2019 and June 30, 2019, respectively	`CommonStockValue`	$2.76B	USD	Point-in-time
Authorized755 million shares, Issued327 million shares at December 31, 2019 and June 30, 2019, respectively	`CommonStockValue`	$2.75B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$5.43B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$449.00M	USD	Point-in-time
Common shares in treasury, at cost: 35 million shares and 28 million shares at December 31, 2019 and June 30, 2019, respectively	`TreasuryStockValue`	$1.79B	USD	Point-in-time
Common shares in treasury, at cost: 35 million shares and 28 million shares at December 31, 2019 and June 30, 2019, respectively	`TreasuryStockValue`	$2.10B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-79.00M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-103.00M	USD	Point-in-time
Total Cardinal Health, Inc. shareholders' equity	`StockholdersEquity`	$6.33B	USD	Point-in-time
Total Cardinal Health, Inc. shareholders' equity	`StockholdersEquity`	$999.00M	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$3.00M	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$2.00M	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$6.04B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$903.00M	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$6.33B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$5.91B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.00B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$6.06B	USD	Point-in-time
Total liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$40.96B	USD	Point-in-time
Total liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$41.04B	USD	Point-in-time

Income Statement 88 line items

Line Item	Tag	Value	Unit	Period
Revenue	`Revenues`	$72.95B	USD	2 Qtrs
Revenue	`Revenues`	$39.73B	USD	1 Quarter
Revenue	`Revenues`	$77.08B	USD	2 Qtrs
Revenue	`Revenues`	$37.74B	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$69.56B	USD	2 Qtrs
Cost of products sold	`CostOfGoodsAndServicesSold`	$38.02B	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$36.01B	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$73.68B	USD	2 Qtrs
Gross margin	`GrossProfit`	$1.71B	USD	1 Quarter
Gross margin	`GrossProfit`	$3.39B	USD	2 Qtrs
Gross margin	`GrossProfit`	$1.73B	USD	1 Quarter
Gross margin	`GrossProfit`	$3.40B	USD	2 Qtrs
Distribution, selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$1.16B	USD	1 Quarter
Distribution, selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$2.27B	USD	2 Qtrs
Distribution, selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$2.22B	USD	2 Qtrs
Distribution, selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$1.06B	USD	1 Quarter
Restructuring and employee severance	`RestructuringCharges`	$12.00M	USD	1 Quarter
Restructuring and employee severance	`RestructuringCharges`	$86.00M	USD	2 Qtrs
Restructuring and employee severance	`RestructuringCharges`	$44.00M	USD	2 Qtrs
Restructuring and employee severance	`RestructuringCharges`	$56.00M	USD	1 Quarter
Amortization and other acquisition-related costs	`Amortizationandotheracquisitionrelatedcosts`	$133.00M	USD	1 Quarter
Amortization and other acquisition-related costs	`Amortizationandotheracquisitionrelatedcosts`	$314.00M	USD	2 Qtrs
Amortization and other acquisition-related costs	`Amortizationandotheracquisitionrelatedcosts`	$157.00M	USD	1 Quarter
Amortization and other acquisition-related costs	`Amortizationandotheracquisitionrelatedcosts`	$265.00M	USD	2 Qtrs
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$-8.00M	USD	1 Quarter
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$-8.00M	USD	2 Qtrs
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$-7.00M	USD	1 Quarter
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$503.00M	USD	2 Qtrs
Litigation (recoveries)/charges, net	`GainLossRelatedToLitigationSettlement`	$-21.00M	USD	1 Quarter
Litigation (recoveries)/charges, net	`GainLossRelatedToLitigationSettlement`	$15.00M	USD	1 Quarter
Litigation (recoveries)/charges, net	`GainLossRelatedToLitigationSettlement`	$-3.00M	USD	2 Qtrs
Litigation (recoveries)/charges, net	`GainLossRelatedToLitigationSettlement`	$-5.69B	USD	2 Qtrs
Operating earnings/(loss)	`OperatingIncomeLoss`	$-4.93B	USD	2 Qtrs
Operating earnings/(loss)	`OperatingIncomeLoss`	$1.32B	USD	2 Qtrs
Operating earnings/(loss)	`OperatingIncomeLoss`	$334.00M	USD	1 Quarter
Operating earnings/(loss)	`OperatingIncomeLoss`	$504.00M	USD	1 Quarter
Other (income)/expense, net	`OtherNonoperatingIncomeExpense`	$-2.00M	USD	2 Qtrs
Other (income)/expense, net	`OtherNonoperatingIncomeExpense`	$-21.00M	USD	1 Quarter
Other (income)/expense, net	`OtherNonoperatingIncomeExpense`	$12.00M	USD	1 Quarter
Other (income)/expense, net	`OtherNonoperatingIncomeExpense`	$-25.00M	USD	2 Qtrs
Interest expense, net	`InterestExpense`	$63.00M	USD	1 Quarter
Interest expense, net	`InterestExpense`	$129.00M	USD	2 Qtrs
Interest expense, net	`InterestExpense`	$76.00M	USD	1 Quarter
Interest expense, net	`InterestExpense`	$152.00M	USD	2 Qtrs
Loss on Extinguishment of Debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	2 Qtrs
Loss on Extinguishment of Debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Loss on Extinguishment of Debt	`GainsLossesOnExtinguishmentOfDebt`	$-4.00M	USD	1 Quarter
Loss on Extinguishment of Debt	`GainsLossesOnExtinguishmentOfDebt`	$-4.00M	USD	2 Qtrs
Earnings/(loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$407.00M	USD	1 Quarter
Earnings/(loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-5.07B	USD	2 Qtrs
Earnings/(loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$279.00M	USD	1 Quarter
Earnings/(loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$1.14B	USD	2 Qtrs
Provision for/(benefit from) income taxes	`IncomeTaxExpenseBenefit`	$59.00M	USD	1 Quarter
Provision for/(benefit from) income taxes	`IncomeTaxExpenseBenefit`	$269.00M	USD	2 Qtrs
Provision for/(benefit from) income taxes	`IncomeTaxExpenseBenefit`	$-364.00M	USD	2 Qtrs
Provision for/(benefit from) income taxes	`IncomeTaxExpenseBenefit`	$126.00M	USD	1 Quarter
Net earnings/(loss)	`ProfitLoss`	$-4.70B	USD	2 Qtrs
Net earnings/(loss)	`ProfitLoss`	$220.00M	USD	1 Quarter
Net earnings/(loss)	`ProfitLoss`	$281.00M	USD	1 Quarter
Net earnings/(loss)	`ProfitLoss`	$874.00M	USD	2 Qtrs
Less: Net earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Less: Net earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.00M	USD	2 Qtrs
Less: Net earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.00M	USD	1 Quarter
Less: Net earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.00M	USD	2 Qtrs
Net earnings/(loss) attributable to Cardinal Health, Inc.	`NetIncomeLoss`	$873.00M	USD	2 Qtrs
Net earnings/(loss) attributable to Cardinal Health, Inc.	`NetIncomeLoss`	$220.00M	USD	1 Quarter
Net earnings/(loss) attributable to Cardinal Health, Inc.	`NetIncomeLoss`	$280.00M	USD	1 Quarter
Net earnings/(loss) attributable to Cardinal Health, Inc.	`NetIncomeLoss`	$-4.70B	USD	2 Qtrs
Basic (in shares)	`IncomeLossFromContinuingOperationsPerBasicShare`	$0.75	USD	1 Quarter
Basic (in shares)	`IncomeLossFromContinuingOperationsPerBasicShare`	$0.94	USD	1 Quarter
Basic (in shares)	`IncomeLossFromContinuingOperationsPerBasicShare`	$2.90	USD	2 Qtrs
Basic (in shares)	`IncomeLossFromContinuingOperationsPerBasicShare`	$-15.99	USD	2 Qtrs
Income (Loss) from Continuing Operations, Per Diluted Share	`IncomeLossFromContinuingOperationsPerDilutedShare`	$2.88	USD	2 Qtrs
Income (Loss) from Continuing Operations, Per Diluted Share	`IncomeLossFromContinuingOperationsPerDilutedShare`	$0.93	USD	1 Quarter
Income (Loss) from Continuing Operations, Per Diluted Share	`IncomeLossFromContinuingOperationsPerDilutedShare`	$0.75	USD	1 Quarter
Income (Loss) from Continuing Operations, Per Diluted Share	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-15.99	USD	2 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	294.00M	shares	2 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	302.00M	shares	2 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	299.00M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	292.00M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	294.00M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	300.00M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	294.00M	shares	2 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	303.00M	shares	2 Qtrs
Cash dividends declared per common share	`CommonStockDividendsPerShareDeclared`	$0.95	USD	2 Qtrs
Cash dividends declared per common share	`CommonStockDividendsPerShareDeclared`	$0.48	USD	1 Quarter
Cash dividends declared per common share	`CommonStockDividendsPerShareDeclared`	$0.96	USD	2 Qtrs
Cash dividends declared per common share	`CommonStockDividendsPerShareDeclared`	$0.48	USD	1 Quarter

Cash Flow Statement 68 line items

Line Item	Tag	Value	Unit	Period
Net earnings/(loss)	`ProfitLoss`	$-4.70B	USD	2 Qtrs
Net earnings/(loss)	`ProfitLoss`	$220.00M	USD	1 Quarter
Net earnings/(loss)	`ProfitLoss`	$281.00M	USD	1 Quarter
Net earnings/(loss)	`ProfitLoss`	$874.00M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$464.00M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$498.00M	USD	2 Qtrs
Loss on Sale of Investments	`LossOnSaleOfInvestments`	$2.00M	USD	2 Qtrs
Loss on Sale of Investments	`LossOnSaleOfInvestments`	-	USD	2 Qtrs
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$-8.00M	USD	1 Quarter
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$-8.00M	USD	2 Qtrs
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$-7.00M	USD	1 Quarter
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$503.00M	USD	2 Qtrs
Loss on Extinguishment of Debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	2 Qtrs
Loss on Extinguishment of Debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Loss on Extinguishment of Debt	`GainsLossesOnExtinguishmentOfDebt`	$-4.00M	USD	1 Quarter
Loss on Extinguishment of Debt	`GainsLossesOnExtinguishmentOfDebt`	$-4.00M	USD	2 Qtrs
Share-based compensation	`ShareBasedCompensation`	$41.00M	USD	2 Qtrs
Share-based compensation	`ShareBasedCompensation`	$41.00M	USD	2 Qtrs
Provision for bad debts	`ProvisionForDoubtfulAccounts`	$40.00M	USD	2 Qtrs
Provision for bad debts	`ProvisionForDoubtfulAccounts`	$47.00M	USD	2 Qtrs
(Increase)/decrease in trade receivables	`IncreaseDecreaseInReceivables`	$-121.00M	USD	2 Qtrs
(Increase)/decrease in trade receivables	`IncreaseDecreaseInReceivables`	$191.00M	USD	2 Qtrs
Increase in inventories	`IncreaseDecreaseInInventories`	$753.00M	USD	2 Qtrs
Increase in inventories	`IncreaseDecreaseInInventories`	$991.00M	USD	2 Qtrs
Increase/(decrease) in accounts payable	`IncreaseDecreaseInAccountsPayable`	$941.00M	USD	2 Qtrs
Increase/(decrease) in accounts payable	`IncreaseDecreaseInAccountsPayable`	$-77.00M	USD	2 Qtrs
Other accrued liabilities and operating items, net	`IncreaseDecreaseInOtherOperatingCapitalNet`	$-5.13B	USD	2 Qtrs
Other accrued liabilities and operating items, net	`IncreaseDecreaseInOtherOperatingCapitalNet`	$213.00M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$736.00M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$44.00M	USD	2 Qtrs
Acquisition of subsidiaries, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	2 Qtrs
Acquisition of subsidiaries, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$21.00M	USD	2 Qtrs
Additions to property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$116.00M	USD	2 Qtrs
Additions to property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$149.00M	USD	2 Qtrs
Purchase of investments	`Purchaseofavailableforsalesecuritiesandotherinvestments`	$10.00M	USD	2 Qtrs
Purchase of investments	`Purchaseofavailableforsalesecuritiesandotherinvestments`	$6.00M	USD	2 Qtrs
Proceeds from sale of investments	`Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments`	$2.00M	USD	2 Qtrs
Proceeds from sale of investments	`Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments`	$2.00M	USD	2 Qtrs
Proceeds from divestitures and disposal of property and equipment and held for sale assets	`Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets`	$2.00M	USD	2 Qtrs
Proceeds from divestitures and disposal of property and equipment and held for sale assets	`Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets`	$740.00M	USD	2 Qtrs
Net cash provided by/(used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$595.00M	USD	2 Qtrs
Net cash provided by/(used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-151.00M	USD	2 Qtrs
Net change in short-term borrowings	`ProceedsFromRepaymentsOfShortTermDebt`	$681.00M	USD	2 Qtrs
Net change in short-term borrowings	`ProceedsFromRepaymentsOfShortTermDebt`	-	USD	2 Qtrs
Reduction of long-term obligations	`RepaymentsOfLongTermDebt`	$2.00M	USD	2 Qtrs
Reduction of long-term obligations	`RepaymentsOfLongTermDebt`	$793.00M	USD	2 Qtrs
Net proceeds/(tax withholdings) from share-based compensation	`Netproceedstaxwithholdingsfromsharebasedcompensation`	$-11.00M	USD	2 Qtrs
Net proceeds/(tax withholdings) from share-based compensation	`Netproceedstaxwithholdingsfromsharebasedcompensation`	$-13.00M	USD	2 Qtrs
Dividends on common shares	`PaymentsOfDividendsCommonStock`	$287.00M	USD	2 Qtrs
Dividends on common shares	`PaymentsOfDividendsCommonStock`	$293.00M	USD	2 Qtrs
Payments for Repurchase of Common Stock	`PaymentsForRepurchaseOfCommonStock`	$350.00M	USD	2 Qtrs
Payments for Repurchase of Common Stock	`PaymentsForRepurchaseOfCommonStock`	-	USD	1 Quarter
Payments for Repurchase of Common Stock	`PaymentsForRepurchaseOfCommonStock`	-	USD	1 Quarter
Payments for Repurchase of Common Stock	`PaymentsForRepurchaseOfCommonStock`	$600.00M	USD	2 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-908.00M	USD	2 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-760.00M	USD	2 Qtrs
Effect of exchange rates changes on cash and equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-5.00M	USD	2 Qtrs
Effect of exchange rates changes on cash and equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-4.00M	USD	2 Qtrs
Net increase/(decrease) in cash and equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-872.00M	USD	2 Qtrs
Net increase/(decrease) in cash and equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$419.00M	USD	2 Qtrs
Cash and equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$2.18B	USD	Point-in-time
Cash and equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$1.76B	USD	Point-in-time
Cash and equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$1.66B	USD	Point-in-time
Cash and equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$2.53B	USD	Point-in-time
Cash and equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$2.18B	USD	Point-in-time
Cash and equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$1.76B	USD	Point-in-time
Cash and equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$1.66B	USD	Point-in-time
Cash and equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$2.53B	USD	Point-in-time

Stockholders Equity 56 line items

Line Item	Tag	Value	Unit	Period
Balance at beginning of period (in shares)	`CommonStockSharesIssued`	327.00M	shares	Point-in-time
Balance at beginning of period (in shares)	`CommonStockSharesIssued`	327.00M	shares	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$6.04B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$903.00M	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$6.33B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$5.91B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.00B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$6.06B	USD	Point-in-time
Treasury, balance at beginning of period (in shares)	`TreasuryStockShares`	28.00M	shares	Point-in-time
Treasury, balance at beginning of period (in shares)	`TreasuryStockShares`	35.00M	shares	Point-in-time
Treasury, balance at beginning of period	`TreasuryStockValue`	$1.79B	USD	Point-in-time
Treasury, balance at beginning of period	`TreasuryStockValue`	$2.10B	USD	Point-in-time
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	`ProfitLoss`	$-4.70B	USD	2 Qtrs
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	`ProfitLoss`	$220.00M	USD	1 Quarter
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	`ProfitLoss`	$281.00M	USD	1 Quarter
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	`ProfitLoss`	$874.00M	USD	2 Qtrs
Net Income (Loss) Attributable to Parent	`NetIncomeLoss`	$873.00M	USD	2 Qtrs
Net Income (Loss) Attributable to Parent	`NetIncomeLoss`	$220.00M	USD	1 Quarter
Net Income (Loss) Attributable to Parent	`NetIncomeLoss`	$280.00M	USD	1 Quarter
Net Income (Loss) Attributable to Parent	`NetIncomeLoss`	$-4.70B	USD	2 Qtrs
Other Comprehensive Income (Loss), Net of Tax	`OtherComprehensiveIncomeLossNetOfTax`	$-2.00M	USD	1 Quarter
Other Comprehensive Income (Loss), Net of Tax	`OtherComprehensiveIncomeLossNetOfTax`	$-24.00M	USD	2 Qtrs
Other Comprehensive Income (Loss), Net of Tax	`OtherComprehensiveIncomeLossNetOfTax`	$-31.00M	USD	2 Qtrs
Other Comprehensive Income (Loss), Net of Tax	`OtherComprehensiveIncomeLossNetOfTax`	$-27.00M	USD	1 Quarter
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-31.00M	USD	2 Qtrs
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-24.00M	USD	2 Qtrs
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-2.00M	USD	1 Quarter
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-27.00M	USD	1 Quarter
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture	`StockIssuedDuringPeriodValueShareBasedCompensation`	$27.00M	USD	2 Qtrs
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture	`StockIssuedDuringPeriodValueShareBasedCompensation`	$23.00M	USD	1 Quarter
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture	`StockIssuedDuringPeriodValueShareBasedCompensation`	$21.00M	USD	1 Quarter
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture	`StockIssuedDuringPeriodValueShareBasedCompensation`	$30.00M	USD	2 Qtrs
Payments for Repurchase of Common Stock	`PaymentsForRepurchaseOfCommonStock`	$350.00M	USD	2 Qtrs
Payments for Repurchase of Common Stock	`PaymentsForRepurchaseOfCommonStock`	-	USD	1 Quarter
Payments for Repurchase of Common Stock	`PaymentsForRepurchaseOfCommonStock`	-	USD	1 Quarter
Payments for Repurchase of Common Stock	`PaymentsForRepurchaseOfCommonStock`	$600.00M	USD	2 Qtrs
Dividends	`Dividends`	$284.00M	USD	2 Qtrs
Dividends	`Dividends`	$143.00M	USD	1 Quarter
Dividends	`Dividends`	$286.00M	USD	2 Qtrs
Dividends	`Dividends`	$143.00M	USD	1 Quarter
Other	`StockholdersEquityOther`	$1.00M	USD	2 Qtrs
Other	`StockholdersEquityOther`	-	USD	2 Qtrs
Other	`StockholdersEquityOther`	$1.00M	USD	1 Quarter
Other	`StockholdersEquityOther`	$-2.00M	USD	1 Quarter
Balance at end of period (in shares)	`CommonStockSharesIssued`	327.00M	shares	Point-in-time
Balance at end of period (in shares)	`CommonStockSharesIssued`	327.00M	shares	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$6.04B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$903.00M	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$6.33B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$5.91B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.00B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$6.06B	USD	Point-in-time
Treasury, balance at end of period (in shares)	`TreasuryStockShares`	28.00M	shares	Point-in-time
Treasury, balance at end of period (in shares)	`TreasuryStockShares`	35.00M	shares	Point-in-time
Treasury, balance at end of period	`TreasuryStockValue`	$1.79B	USD	Point-in-time
Treasury, balance at end of period	`TreasuryStockValue`	$2.10B	USD	Point-in-time

Comprehensive Income 28 line items

Line Item	Tag	Value	Unit	Period
Net earnings/(loss)	`ProfitLoss`	$-4.70B	USD	2 Qtrs
Net earnings/(loss)	`ProfitLoss`	$220.00M	USD	1 Quarter
Net earnings/(loss)	`ProfitLoss`	$281.00M	USD	1 Quarter
Net earnings/(loss)	`ProfitLoss`	$874.00M	USD	2 Qtrs
Foreign currency translation adjustments and other	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-29.00M	USD	2 Qtrs
Foreign currency translation adjustments and other	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-26.00M	USD	1 Quarter
Foreign currency translation adjustments and other	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-18.00M	USD	2 Qtrs
Foreign currency translation adjustments and other	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-1.00M	USD	1 Quarter
Net unrealized loss on derivative instruments, net of tax	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	$-2.00M	USD	2 Qtrs
Net unrealized loss on derivative instruments, net of tax	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	$-6.00M	USD	2 Qtrs
Net unrealized loss on derivative instruments, net of tax	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	$-1.00M	USD	1 Quarter
Net unrealized loss on derivative instruments, net of tax	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	$-1.00M	USD	1 Quarter
Total other comprehensive loss, net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-2.00M	USD	1 Quarter
Total other comprehensive loss, net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-24.00M	USD	2 Qtrs
Total other comprehensive loss, net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-31.00M	USD	2 Qtrs
Total other comprehensive loss, net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-27.00M	USD	1 Quarter
Total comprehensive income/(loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$254.00M	USD	1 Quarter
Total comprehensive income/(loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-4.72B	USD	2 Qtrs
Total comprehensive income/(loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$218.00M	USD	1 Quarter
Total comprehensive income/(loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$843.00M	USD	2 Qtrs
Less: Net earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Less: Net earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.00M	USD	2 Qtrs
Less: Net earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.00M	USD	1 Quarter
Less: Net earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.00M	USD	2 Qtrs
Total comprehensive income attributable to Cardinal Health, Inc.	`ComprehensiveIncomeNetOfTax`	$842.00M	USD	2 Qtrs
Total comprehensive income attributable to Cardinal Health, Inc.	`ComprehensiveIncomeNetOfTax`	$-4.73B	USD	2 Qtrs
Total comprehensive income attributable to Cardinal Health, Inc.	`ComprehensiveIncomeNetOfTax`	$253.00M	USD	1 Quarter
Total comprehensive income attributable to Cardinal Health, Inc.	`ComprehensiveIncomeNetOfTax`	$218.00M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.